Singhvi Rahul - Insider Non-Derivative Transactions at Kairos Pharma, LTD. (KAPA) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Oct 8, 2025, Singhvi Rahul's relationship to Kairos Pharma, LTD. (KAPA) is Director, and currently has 49,204 shares of COMMON STOCK.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KAPA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Singhvi Rahul - Insider Non-Derivative Transactions of KAPA COMMON STOCK

Singhvi Rahul - Insider Non-Derivative Transactions at KAPA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 9, 2025	Acquisition -- (COMMON STOCK)	19084	0	49204